Caris Life Sciences News
Circulating Microvesicles Demonstrate Promise for Cancer Testing
Three Posters on Novel Technology Presented at American Association for Cancer Research (AACR) IRVING, TX, April 4th, 2012 — Caris Life Sciences, a leading biosciences company focused on enabling precise and personalized healthcare through molecular profiling and blood-based diagnostic services, …
Novel Findings for Molecular Profiling of Head and Neck Squamous Cell Carcinoma (HNSCC) Presented at the 2012 Multidisciplinary Head & Neck Cancer Symposium
First Comprehensive Analysis of Biomarkers Associated with this Aggressive Form of Cancer Demonstrates Clinical Utility of Molecular Profiling in Identifying Treatment Options When Therapeutic Ambiguities Exist. IRVING, TX, February 2, 2012 – Caris Life Sciences™, Inc., a leading biosciences company …
Caris Life Sciences and Miraca Holdings Complete Sale of Anatomic Pathology Business
Tokyo, Japan & Irving, Texas – November 22, 2011 – Miraca Holdings Inc. (“Miraca”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas specializing in the development and …
Caris Life Sciences Presents Study at AACR-NCI-EORTC International Conference
Data Highlights How the Information Provided by Molecular Profiling Can Be Useful in Guiding Therapy Selection for Advanced Prostate Cancer IRVING, Texas – November 17, 2011 – Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and …
Caris Life Sciences Reports Key Findings at the 59th Annual Scientific Meeting of the American Society of Cytopathology
Data Highlights Clinical Utility of Molecular Profiling in Absence of Traditional Tissue Samples IRVING, Texas – November 8, 2011 – Caris Life Sciences, Inc.™, a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic …
Kathleen Danenberg Joins Caris Life Sciences’ Executive Team as Senior Vice President, Professional Affairs
Newly Added Position Will Develop and Expand Molecular Profiling Clinical Trial Strategy IRVING, Texas – October 19, 2011 – Caris Life Sciences, Inc.™, a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, …
Caris Life Sciences Highlights Gene Expression Profiling Findings at 12th Annual International Congress of Human Genetics
Data Presented Shows Clinical Utility of Molecular Profiling Helping Physicians Select More Effective Therapeutic Treatments for Cancer Patients IRVING, TX, October 14-15, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through …
Caris Foundation announces $2.5 Million Commitment to Pink Ribbon-Red Ribbon Partnership
Gift will fund the management and coordination of the Partnership as well as offer discounted pathology Irving, TX, September 16, 2011 – The Caris Foundation, a non-profit private foundation established in Irving, Texas, to aid impoverished people by helping provide …
Caris Life Sciences Presents Key Biomarker Findings at 2011 ASCO Breast Cancer Symposium
Data Highlights Potential Clinical Utility of Molecular Profiling in Uncovering Therapeutic Options to Treat Breast Cancer IRVING, TX, September 13, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest …
Caris Life Sciences Presents Circulating Microvesicle Research Findings at American Urological Association Annual Meeting
Data Shows Diagnostic Promise for Blood-Based Prostate Cancer Detection Test IRVING, TX, May 18, 2011 — Caris Life Sciences, Inc., a leading bioscience company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and …
About Us
“WE INTEND TO HELP RELIEVE THE SUFFERING OF AS MANY PEOPLE AS POSSIBLE”
David D. Halbert Chairman & CEO
